Context Therapeutics Inc (CNTX)
1.39
-0.11
(-7.33%)
USD |
NASDAQ |
Nov 22, 16:00
1.32
-0.07
(-5.04%)
After-Hours: 20:00
Context Therapeutics Cash from Investing (Quarterly): -14.76M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -14.76M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.50M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.0018M |
| March 31, 2022 | -0.035M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.25M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-14.76M
Minimum
Sep 2024
--
Maximum
Jun 2020
-1.110M
Average
--
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| Collegium Pharmaceutical Inc | -248.96M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.713M |
| Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.933M |
| Cash from Financing (Quarterly) | -0.0446M |
| Free Cash Flow | -31.63M |
| Free Cash Flow Per Share (Quarterly) | -0.2074 |
| Free Cash Flow Yield | -54.39% |